Headache and multiple sclerosis: comorbid emotional and insomnia disorders
https://doi.org/10.30629/2658-79472025-30-5-40-45
Abstract
Multiple sclerosis (MS) is often accompanied by various neurological disorders, including headache, which is common among patients with MS, but its relationship with other comorbid conditions such as depression and insomnia remains poorly understood.
The aim. To assess the incidence of headache in patients with MS, and to examine the incidence and severity of emotional disorders (depression, anxiety) and insomnia in patients with MS.
Material and methods. The study included 60 patients who were divided into 3 groups of 20 people each. The fi rst group consisted of patients with MS complaining of headache, the second group (comparison group) consisted of patients with multiple sclerosis without headache. The control group consisted of 20 patients with primary headache (tension headache and migraine). A numerical pain rating scale was used to assess headache intensity. Emotional disorders were assessed using the Beck Depression Inventory and the Spielberger–Hanin Anxiety Scale, and the severity of sleep disorders was assessed using the Pittsburgh Sleep Quality Index Questionnaire. Descriptive statistics methods were used for statistical analysis. Quantitative indicators with a normal sample distribution were described using arithmetic means (M) and standard deviations (SD). Comparison of percentages in the analysis of multifield contingency tables was performed using the Pearson chi-square test. Differences were considered statistically significant at p < 0.05.
Results. The average severity of headache according to the digital pain rating scale was 5.42 ± 1.34 points (the fi rst group — 5.75 ± 1.33, the control group — 5.10 ± 1.29, p = 0.126), which corresponds to moderate severity of cephalalgia. It was found that the presence of headache is associated with an increased level of depression and anxiety, as well as with an increase in the number of cases of insomnia. Statistically significant differences in the severity of depression between the first and control groups were noted (p < 0.001), with a greater number of patients with MS and concomitant headache experiencing depression, and also more often demonstrating a high level of situational and personal anxiety. The intensity of headache correlates with the severity of situational and personal anxiety. Sleep problems are more common in patients with MS with headache, while sleep disorders increase with the growth of neurological deficit.
Conclusion. The obtained data indicate the need for a comprehensive approach to the treatment of patients with MS, including assessment and correction of not only the main neurological symptoms, but also concomitant emotional and insomnia disorders. Headache may be considered as an important indicator of the patient's general condition and the potential risk of developing the studied comorbid conditions.
About the Authors
A. I. RaevskayaРоссия
Stavropol.
I. A. Vyshlova
Россия
Stavropol.
N. M. Tkachenko
Россия
Stavropol.
I. V. Konareva
Россия
Stavropol.
D. V. Lychagin
Россия
Stavropol.
N. N. Kochkarov
Россия
Stavropol.
S. M. Karpov
Россия
Stavropol.
References
1. Kiselev D.V., Spirin N.N., Baranova N.S., Karpova M.S., Gris M.S. Multiple sclerosis and migraine: clinical and pathogenetic aspects of comorbidity. Nervous diseases (Nervnye bolezni). 2023;4:35–42. (In Russ.). https://doi.org/10.24412/2226-0757-2023-13044
2. Larin G.V., Larina E.M., Raevskaya I.A., Vyshlova I.A., Karpov S.M. Epidemiological characteristics of multiple sclerosis in the Stavropol Territory. Russian Neurological Journal (Rossijskij Nevrologicheskiy Zhurnal). 2019;24(4):16–22 (In Russ.). https://doi.org/10.30629/2658-7947-2024-29-1-46-51
3. Abdel Naseer M, Shehata HS, Khalil S, Fouad AM, Abdelghany H. Prevalence of primary headaches in multiple sclerosis patients. Mult Scler Relat Disord. 2024;86:105602. https://doi.org/10.1016/j.msard.2024.105602
4. Zeng X, Dorstyn DS, Edwards G, Kneebone I. The prevalence of insomnia in multiple sclerosis: A meta-analysis. Sleep Med Rev. 2023;72:101842. https://doi.org/10.1016/j.smrv.2023.101842
5. Boeschoten RE, Braamse AMJ, Beekman ATF, Cuijpers P, van Oppen P, Dekker J, Uitdehaag BMJ. Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis. J Neurol Sci. 2017;372:331–341. https://doi.org/10.1016/j.jns.2016.11.067
6. Putzki N, Katsarava Z. Headache in multiple sclerosis. Curr Pain Headache Rep. 2010;14(4):316–20. https://doi.org/10.1007/s11916-010-0126-6
7. Buczek E, Mitosek-Szewczyk K, Szajnoga B, WierzchowskaCioch E. Bóle głowy a stwardnienie rozsiane [Headaches and multiple sclerosis]. Wiad Lek. 2014;67(2 Pt 1):97–100.
8. Beckmann Y, Türe S. Headache characteristics in multiple sclerosis. Mult Scler Relat Disord. 2019;27:112–116. https://doi.org/10.1016/j.msard.2018.09.022
9. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–1452. https://doi.org/10.1212/wnl.33.11.1444
10. Foley PL, Vesterinen HM, Laird BJ, Sena ES, Colvin LA, Chandran S, MacLeod MR, Fallon MT. Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis. Pain. 2013;154(5):632–642. https://doi.org/10.1016/j.pain.2012.12.002
11. Moisset X, Ouchchane L, Guy N, Bayle DJ, Dallel R, Clavelou P. Migraine headaches and pain with neuropathic characteristics: comorbid conditions in patients with multiple sclerosis. Pain. 2013;154(12):2691–2699. https://doi.org/10.1016/j.pain.2013.07.050
12. Wang L, Zhang J, Deng ZR, Zu MD, Wang Y. The epidemiology of primary headaches in patients with multiple sclerosis. Brain Behav. 2021;11(1):e01830. https://doi.org/10.1002/brb3.1830
13. La Mantia L, Prone V. Headache in multiple sclerosis and autoimmune disorders. Neurol Sci. 2015;36 Suppl 1:75–8. https://doi.org/10.1007/s10072-015-2146-9
14. Urits I, Adamian L, Fiocchi J, Hoyt D, Ernst C, Kaye AD, Viswanath O. Advances in the Understanding and Management of Chronic Pain in Multiple Sclerosis: a Comprehensive Review. Curr Pain Headache Rep. 2019;23(8):59. https://doi.org/10.1007/s11916-019-0800-2
15. Gee JR, Chang J, Dublin AB, Vijayan N. The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis. Headache. 2005;45(6):670–7. https://doi.org/10.1111/j.1526-4610.2005.05136.x
16. Beckmann Y, Türe S. Headache characteristics in multiple sclerosis. Mult Scler Relat Disord. 2019;27:112–116. https://doi.org/10.1016/j.msard.2018.09.02
17. Mijajlović MD, Aleksić VM, Covičković Šternić NM. Cluster headache as a fi rst manifestation of multiple sclerosis: case report and literature review. Neuropsychiatr Dis Treat. 2014;10:2269– 74. https://doi.org/10.2147/NDT.S73491
18. Gentile S, Ferrero M, Vaula G, Rainero I, Pinessi L. Cluster headache attacks and multiple sclerosis. J Headache Pain. 2007; 8(4):245–7. https://doi.org/10.1007/s10194-007-0405-8
19. Patten SB, Marrie RA, Carta MG. Depression in multiple sclerosis. Int Rev Psychiatry. 2017;29(5):463–472. https://doi.org/10.1080/09540261.2017.1322555
20. Karimi S, Andayeshgar B, Khatony A. Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study. BMC Psychiatry. 2020;20(1):166. https://doi.org/10.1186/s12888-020-02579-z
21. Rezapour A, Almasian Kia A, Goodarzi S, Hasoumi M, Nouraei Motlagh S, Vahedi S. The impact of disease characteristics on multiple sclerosis patients' quality of life. Epidemiol Health. 2017;39:e2017008. https://doi.org/10.4178/epih.e2017008
22. Alsaadi T, El Hammasi K, Shahrour TM, Shakra M, Turkawi L, Mudhafar A, Diab L, Raoof M. Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study. Mult Scler Int. 2015;2015:487159. https://doi.org/10.1155/2015/487159
23. Labuz-Roszak B, Kubicka-Bączyk K, Pierzchała K, Machowska-Majchrzak A, Skrzypek M. Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis. Neurol Neurochir Pol. 2012;46(4):309–17. https://doi.org/10.5114/ninp.2012.30261
24. Rzepka M, Toś M, Boroń M, Gibas K, Krzystanek E. Relationship between Fatigue and Physical Activity in a Polish Cohort of Multiple Sclerosis Patients. Medicina (Kaunas). 2020;56(12):726. https://doi.org/10.3390/medicina56120726
25. Fidao A, De Livera A, Nag N, Neate S, Jelinek GA, SimpsonYap S. Depression mediates the relationship between fatigue and mental health-related quality of life in multiple sclerosis. Mult Scler Relat Disord. 2021;47:102620. https://doi.org/10.1016/j.msard.2020.102620
26. Dahl OP, Stordal E, Lydersen S, Midgard R. Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trøndelag County, Norway. Mult Scler. 2009;15(12):1495– 501. https://doi.org/10.1177/1352458509351542
27. Forbes A, While A, Mathes L, Griffi ths P. Health problems and health-related quality of life in people with multiple sclerosis. Clin Rehabil. 2006;20(1):67–78. https://doi.org/10.1191/0269215506cr880oa
28. Möller A, Wiedemann G, Rohde U, Backmund H, Sonntag A. Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psychiatr Scand. 1994;89(2):117–21. https://doi.org/10.1111/j.1600-0447.1994.tb01497.x
29. Bhattarai JJ, Patel KS, Dunn KM, Brown A, Opelt B, Hughes AJ. Sleep disturbance and fatigue in multiple sclerosis: A systematic review and meta-analysis. Mult Scler J Exp Transl Clin. 2023;9(3):20552173231194352. https://doi.org/10.1177/20552173231194352
30. Braley TJ, Boudreau EA. Sleep Disorders in Multiple Sclerosis. Curr Neurol Neurosci Rep. 2016;16(5):50. https://doi.org/10.1007/s11910-016-0649-2
31. Bøe Lunde HM, Aae TF, Indrevåg W, Aarseth J, Bjorvatn B, Myhr KM, Bø L. Poor sleep in patients with multiple sclerosis. PLoS One. 2012;7(11):e49996. https://doi.org/10.1371/journal.pone.0049996
32. Garland SN, Scurrey SRM, Ploughman M. Health, Lifestyle and Aging with MS Canadian Consortium. Factors Associated with Poor Sleep in Older Adults with Multiple Sclerosis. Int J Behav Med. 2017;24(6):937–945. https://doi.org/10.1007/s12529-017-9653-4
33. Alhazzani AA, Alshahrani A, Alqahtani M, Alamri R, Alqahtani R, Alqahtani M, Alahmarii M. Insomnia among nondepressed multiple sclerosis patients: a cross-sectional study. Egypt J Neurol Psychiatr Neurosurg. 2018;54(1):17. https://doi.org/10.1186/s41983-018-0016-0
34. Buratti L, Iacobucci DE, Viticchi G, Falsetti L, Lattanzi S, Pulcini A, Silvestrini M. Sleep quality can infl uence the outcome of patients with multiple sclerosis. Sleep Med. 2019;58:56–60. https://doi.org/10.1016/j.sleep.2019.02.020
35. Gebhardt M, Kropp P, Hoff mann F, Zettl UK. Headache in Multiple Sclerosis — Pharmacological Aspects. Curr Pharm Des. 2022;28(6):445–453. https://doi.org/10.2174/1381612827666210922114100
36. Tiseo, C., Vacca, A., Felbush, A. et al. Migraine and sleep disorders: a systematic review. J Headache Pain. 2020;21:126. https://doi.org/10.1186/s10194-020-01192-5
37. Vyshlova I.A., Karpov S.M., Gerbekova I.J. COGNITIVE DYSFUNCTION IN MS Multiple Sclerosis.2020;26(S1):118.
Review
For citations:
Raevskaya A.I., Vyshlova I.A., Tkachenko N.M., Konareva I.V., Lychagin D.V., Kochkarov N.N., Karpov S.M. Headache and multiple sclerosis: comorbid emotional and insomnia disorders. Russian neurological journal. 2025;30(5):40-45. (In Russ.) https://doi.org/10.30629/2658-79472025-30-5-40-45
JATS XML
























